Total planned funding: $542,468,468
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $139,172,828 |
Mozambique | $105,196,382 |
Zambia | $67,686,824 |
Kenya | $40,636,105 |
South Africa | $26,067,623 |
Vietnam | $22,499,165 |
Burundi | $16,526,166 |
Ethiopia | $16,483,511 |
Tanzania | $14,056,556 |
Botswana | $12,432,783 |
Côte d'Ivoire | $9,943,449 |
Zimbabwe | $8,990,190 |
Papua New Guinea | $6,189,195 |
Malawi | $6,070,663 |
Democratic Republic of the Congo | $6,008,286 |
Indonesia | $5,176,155 |
India | $4,545,700 |
Haiti | $4,530,713 |
Guyana | $4,375,000 |
Asia Regional Program | $3,654,954 |
Uganda | $3,360,518 |
Eswatini | $2,863,924 |
South Sudan | $2,751,916 |
Ghana | $2,750,000 |
Caribbean Region | $2,717,206 |
Rwanda | $1,687,592 |
Central America Region | $1,646,143 |
Namibia | $1,210,293 |
Angola | $1,085,000 |
Cameroon | $700,000 |
Lesotho | $653,628 |
Dominican Republic | $500,000 |
Central Asia Region | $300,000 |
Organizational Types
NGO | $542,468,468 |
Program Areas
Care | $162,953,000 |
Treatment | $133,387,755 |
Prevention | $130,509,562 |
Testing | $30,817,003 |
Governance and Systems | $29,955,148 |
Budget Codes
HTXS: Treatment: Adult Treatment | $118,239,155 |
HKID: Care: Orphans and Vulnerable Children | $75,286,980 |
HBHC: Care: Adult Care and Support | $64,118,940 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $56,547,617 |
HVOP: Sexual Prevention: Other Sexual Prevention | $51,378,410 |
HVCT: Testing: HIV Testing and Counseling | $30,817,003 |
PDTX: Treatment: Pediatric Treatment | $15,148,600 |
HVTB: Care: TB/HIV | $12,157,465 |
OHSS: Health Systems Strengthening | $12,068,084 |
PDCS: Care: Pediatric Care and Support | $11,389,615 |
HLAB: Laboratory Infrastructure | $9,825,962 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $9,146,547 |
HVSI: Strategic Information | $8,061,102 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,372,311 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,330,631 |
HMIN: Biomedical Prevention: Injection Safety | $547,298 |
HMBL: Biomedical Prevention: Blood Safety | $186,748 |
HTXD: Treatment: ARV Drugs | $0 |